The Top 25 Healthcare Technology Leaders of New York for 2022
Press Releases
Jul 05, 2022
The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of New York for 2022
NEW YORK, July 5, 2022 /PRNewswire-PRWeb/ — The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of New York for 2022. The awardees on this year’s list direct some of the most influential and innovative companies in the state, from life sciences to medical devices to home services and beyond. Through their deep operational and scientific expertise, they have driven significant growth and development at their companies while providing invaluable products and services to their customers.
Among this year’s honorees is VP and COO Steve Bjornson of Pfizer, which is leading the way in developing treatments for some of the most devastating diseases of our time, from Alzheimer’s to cancer; SVP Jeff Ventimiglia of Medidata Solutions, which is creating hope for millions of patients by leading the digital transformation of the life sciences; and Qi Pan of Sema4, which is revolutionizing healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data.
The leaders on this year’s list and their companies are transforming the healthcare technology industry in myriad ways, from vaccine development to cancer treatment, diagnostics, machine learning and artificial intelligence, and biometrics, among many others. But regardless of their focus or specialty, they are all drastically altering the way we approach healthcare, and they are providing patients with life-changing treatments. Please join us in celebrating The Top 25 Healthcare Technology Leaders of New York for 2022.
Steve Bjornson (Pfizer), Puja Sapra (AstraZeneca), Greg Raskin (Memorial Sloan Kettering Cancer Center), Seth Segel (ConvaTec), Dale Henry (Roswell Park Cancer Institute), Jeff Ventimiglia (Medidata Solutions), Christopher Conway (Curia), Qi Pan (Sema4), Marc Huzansky (Cerner Enviza), Pascal Besman (PharmaMar), Eric Venker (Roivant Sciences), Christopher Schoonmaker (PHASTAR), Esteban Reinhardt (Air Techniques), Badreddin Edris (SpringWorks Therapeutics), Kinnari Patel (Rocket Pharmaceuticals), Zoe Heineman (Diabeloop), Paul Angelico (Chembio Diagnostics), Melanie Goldey (TMRW Life Sciences), Evelyn Harrison (Iveric Bio), Mark Jacobson (Axsome Therapeutics), Luis Voloch (Immunai), Greg Morselli (VitalConnect), Catherine Roggero-Lovisi (Modern Meadow), Hilary Armstrong (AREA 23 on Hudson), Steven L. Colletti (Zymergen)
The full article can be read at https://thehealthcaretechnologyreport.com/
About The Healthcare Technology Report
The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.
Media Contact
Editor, The Healthcare Technology Report, 1 609-365-7014, craig@marketinsightmedia.com
SOURCE The Healthcare Technology Report